PPA
NUVB icon

Parametric Portfolio Associates’s Nuvation Bio NUVB Stock Holding History

Parametric Portfolio Associates’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$208K Buy
39,636
+14,318
+57% +$80.4K ﹤0.01% 3429
2021
Q4 		$215K Buy
25,318
+13,891
+122% +$128K ﹤0.01% 3400
2021
Q3 		$114K Buy
+11,427
New +$104K ﹤0.01% 3518

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Parametric Portfolio Associates's NUVB Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Nuvation Bio (NUVB) stake by 57% in Q1 2022, buying an estimated $80.4K and bringing the position to 39,636 shares worth $208K. The position accounts for ﹤0.01% of the portfolio, ranked #3429.

Parametric Portfolio Associates first reported a position in NUVB in Q3 2021 and has held it in 3 quarters since. The position peaked at $215K in Q4 2021. 117 funds tracked by Wall St. Rank hold NUVB as of Q1 2022.

  • Parametric Portfolio Associates held 39,636 shares of Nuvation Bio worth $208K as of Q1 2022.
  • Parametric Portfolio Associates bought 14,318 Nuvation Bio shares in Q1 2022, an estimated $80.4K.
  • Nuvation Bio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3429 holding.
  • Parametric Portfolio Associates first reported a position in Nuvation Bio in Q3 2021 and has held it in 3 quarters since.
  • Parametric Portfolio Associates's Nuvation Bio position peaked at $215K in Q4 2021.
  • 117 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.